Last reviewed · How we verify

NCT02920723: FOLLOW_EXESAS

Follow-up of the Patients Included in the EXESAS Study

Completed NA Last updated 5 November 2018
What this trial tests

NA trial testing Training in Sleep Apnea Syndromes in 79 participants. Completed in 21 August 2018.

Timeline
1 September 2016
Primary endpoint
21 August 2018
21 August 2018

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Saint Etienne
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment79
Start date1 September 2016
Primary completion21 August 2018
Estimated completion21 August 2018
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Who can join

Adults 40 to 80, any sex, with Sleep Apnea Syndromes or Sleep Apnea, Obstructives. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sleep apnoea affects more than 20% of people over 65 years and is largely underdiagnosed. It does multiply tenfold the occurrence of vascular events, particularly stroke. While Continuous Positive Airway Pressure (CPAP) is currently the Gold standard treatment to prevent cerebrovascular and cardiovascular events, with a major clinical benefit, long term adherence to CPAP is a significant problem and search for alternative treatment is essential.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Training

Trials testing the same drug.

Other recruiting trials for Sleep Apnea Syndromes

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de Saint Etienne trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02920723.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing